Actionable news
All posts from Actionable news
Actionable news in RDHL: Redhill Biopharma Ltd.,

Redhill Biopharma Announces Planned Management Changes EXHIBIT 99.1

The following excerpt is from the company's SEC filing.

RedHill Biopharma Announces Planned Management Changes

TEL-AVIV, Israel, Oct. 22, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that Ori Shilo, a co-founder of RedHill, has informed the Company of his intention to resign from his position as Deputy Chief Executive Officer, Finance and Operations and as a director in order to pursue other opportunities. Mr. Shilo will step down as a director effective November 1, 2015. At the request of the Company, Mr. Shilo has deferred his resignation as Deputy Chief Executive Officer, Finance and Operations until such time as his successor is found and an orderly transition is ensured. RedHill has initiated a search for a full time Chief Financial Officer.

said, "I would like to thank Dror, my partner in founding RedHill, and the entire RedHill team for enabling me to be part of the RedHill success story. I appreciate the opportunity that the Board of Directors provided me to serve the Company and its shareholders. After six intensive and rewarding years at RedHill, it is time for me to pursue other ventures and devote more time to my family. I remain firmly committed to assist RedHill as much as needed during the transition period and thereafter, and I am very confident in RedHill's continued success in the years to come."

Dror Ben-Asher, the Company's Chief Executive Officer and Chairman of the Board of Directors

said: "Ori, a co-founder and a shareholder of the Company, has made a very significant contribution to RedHill in true entrepreneurial fashion since the founding of the Company six years ago. He has been a driving force of RedHill, including our capital raising and listing on the Tel-Aviv Stock Exchange and on Nasdaq Stock Market. Throughout Ori's time with RedHill, he was well respected for his business sense and ideas, approachable demeanor, and high level of integrity. We respect Ori's decision to pursue other opportunities, wishing him every success in the next stage of his career, and we thank him for his very important contribution in getting the Company to where it is today and his willingness to continue supporting the Company."

About RedHill Biopharma Ltd.:

RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) is an emerging Israeli biopharmaceutical company primarily...